PlGF-based testing can help with clinical risk stratification for women with suspected pre-eclampsia, meaning they can be treated appropriately according to their need, improving both patient experience and outcomes and improving the use of scarce system resources.
This programme was selected for adoption and spread through the Health Innovation Network as a Rapid Uptake Product by the Accelerated Access Collaborative and the Innovation and Technology Payment (ITP).
If you want to learn more about the rollout of this intervention in the east please contact nick.clarke@healthinnovationeast.co.uk.
Do you have a great idea that could deliver meaningful change in the real world?
Get involved